Literature DB >> 20414838

Modulating immune responses and inflammation.

Christoph Leder1, Melanie Ziegler, Meinrad Gawaz.   

Abstract

New disease-modifying therapeutic options for immune diseases in general and immune-related cardiovascular diseases are urgently needed. Various innovative therapies are currently developed ranging from small molecules and natural compounds to biopharmaceuticals. This article summarizes the overview of possible points of intervention for an ongoing immune response and lists examples of currently developed therapeutic exploitations of these targets. Research and development for the treatment of autoimmune and inflammatory diseases in general will most likely be fruitful also for therapy of immune-related cardiovascular diseases such as myocarditis and atherosclerosis and should be closely followed by research groups focused on cardiovascular immunology. Thieme Medical Publishers.

Entities:  

Mesh:

Year:  2010        PMID: 20414838     DOI: 10.1055/s-0030-1251507

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  1 in total

1.  Therapeutic potential of caffeic acid phenethyl ester and its anti-inflammatory and immunomodulatory effects (Review).

Authors:  Ferah Armutcu; Sumeyya Akyol; Seyfettin Ustunsoy; Fatime Filiz Turan
Journal:  Exp Ther Med       Date:  2015-03-11       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.